NIH Shortens Brain Disease Meeting, Extends to 8 PM
Published Date: 10/15/2026
Notice
Summary
The Center for Scientific Review changed its special meeting on neurodegenerative disease research from two days to just one day on November 4, 2026, extending the end time to 8:00 p.m. This update affects researchers and staff involved in the meeting, which remains closed to the public. No money changes were mentioned, but the timing tweak helps everyone plan better.
No Economic Impacts Identified for this Document
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-21022, Center For Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in November 2026 to review and decide on grant applications related to cancer, chemistry, kidney health, and small business health projects. These meetings protect private info and trade secrets while helping decide who gets research funding. Scientists and small businesses applying for grants should note these dates for their funding chances.
2026-20705, Prospective Grant of Exclusive License, Inter-Institutional Agreement-Institution Lead: Antibody Specifically Binding to Severe Fever With Thrombocytopenia Syndrome Virus Antigen and Use Thereof
The National Institute of Allergy and Infectious Diseases plans to give Korea National Institute of Health an exclusive license to develop and sell a special antibody that targets a dangerous virus causing severe fever and low platelets. This deal helps speed up turning the invention into real-world treatments. Comments or license requests must be sent by October 26, 2026.
2026-20771, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review at the NIH is holding several closed virtual meetings in early November 2026 to review and evaluate grant applications. These meetings protect private info and trade secrets, affecting researchers seeking funding. No direct money changes are announced, but these reviews decide who gets research grants.
2026-20424, National Cancer Institute; Notice of Meeting
The President's Cancer Panel is holding a free virtual meeting on October 15, 2026, to talk about how GLP-1 medications can help lower cancer risks linked to obesity. Anyone interested can join online or send in comments beforehand. This meeting is a great chance for patients, doctors, and researchers to learn about new ways to fight cancer and improve health.
2026-20365, Center For Scientific Review; Notice of Closed Meetings
The NIH's Center for Scientific Review is holding several closed virtual meetings on October 29-30, 2026, to review and evaluate grant applications. These meetings protect private info and trade secrets while deciding which research projects get funding. Scientists applying for grants in areas like biochemistry, software engineering, and mental health will be affected, with no direct money changes announced but important decisions coming soon.
2026-20151, Notice of NIH Tribal Consultations and Listening Session
The NIH is inviting Tribal leaders and members to join two important meetings and a listening session during the National Congress of American Indians Annual Convention in October 2026. They’ll talk about new health research projects, renewing support for Tribal health centers, and shaping a new Tribal Data Sovereignty Policy. Tribes can also send their thoughts by November 20, 2026, helping shape future health programs and policies.
Previous / Next Documents
Previous: 2026-21098, National Institute on Drug Abuse; Notice of Closed Meeting
The National Institute on Drug Abuse is holding a private virtual meeting on October 27-28, 2026, to review and evaluate the skills and performance of its researchers. This meeting affects scientists working on drug abuse research and helps ensure top-quality work without public disclosure of personal details. No money changes hands, but the review supports ongoing excellence in important health research.
Next: 2026-21100, Certain Systems, Devices, Software, Compositions, Chemicals, and Laboratory Supplies for Studying Proteins; Notice of Commission Determination Not To Review an Initial Determination Finding the Sole Respondent in This Investigation in Default; Request for Written Submissions on Remedy, the Public Interest, and Bonding
The U.S. International Trade Commission has decided not to reconsider its finding that Nanomics Biotechnology, a company from China, failed to respond in a case about protein study tools. Now, the Commission is asking for ideas on how to fix the problem, protect the public, and handle money matters. This affects companies importing or selling these protein research products in the U.S. and could lead to new rules or restrictions soon.